Drug Res (Stuttg) 2018; 68(08): 444-449
DOI: 10.1055/s-0043-124179
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Efficacy and tolerability of a complex homeopathic drug in children suffering from dry cough-A double-blind, placebo-controlled, clinical trial

Hans W. Voß
1   CRO Dr. Kottmann GmbH & Co. KG, Hamm, Germany
,
Andreas Michalsen
2   Immanuel Krankenhaus Berlin-Wannsee, Germany
,
Rainer Brünjes
3   Cassella-med GmbH & Co. KG, Cologne, Germany
› Author Affiliations
Further Information

Publication History

received 07 April 2017

accepted 03 December 2017

Publication Date:
20 March 2018 (online)

Abstract

Background A randomised, placebo-controlled clinical trial in children suffering from acute dry cough was performed to assess the efficacy and tolerability of a complex homeopathic drug (Drosera, Coccus cacti, Cuprum Sulfuricum, Ipecacuanha=Monapax syrup, short: verum).

Methods 89 children received verum and 91 received placebo daily for 7 days (age groups 0.5–3, 4–7 and 8–12 years). The primary efficacy variable was the improvement of the Cough Assessment Score. Tolerability and compliance were also assessed. A confirmatory statistical analysis was performed for the primary efficacy variable and a descriptive analysis for the secondary parameters.

Results The Cough Assessment Score showed an improvement of 5.2±2.6 points for children treated with verum and 3.2±2.6 points in the placebo group (p<0.0001). The difference of the least square means of the improvements was 1.9±0.4. The effect size of Cohen´s d was d=0.77. In all secondary parameters the patients in the verum group showed higher rates of improvement and remission than those in the placebo group. In 15 patients (verum: n=6; placebo: n=9) 18 adverse drug reactions of mild or moderate intensity were observed.

Conclusions Administering verum resulted in a statistically significantly greater improvement of the Cough Assessment Score than the placebo. The tolerability was good and not inferior to that of the placebo.

 
  • References

  • 1 Pratter MR. Cough and the common cold. ACCP evidence-based clinical practice guidelines. Chest 2006; 129: 72S-74S
  • 2 Worrall G. Acute cough in children. Can Fam Physician 2011; 57: 315-318
  • 3 Morice AH, McGarvey L, Pavord I. Recommendations for the management of cough in adults. Thorax 2006; 61 Suppl I i1-i24
  • 4 Zanasi A, Mazzolini M, Tursi F. et al. Homeopathic medicine for acute cough in upper respiratory tract infections and acute bronchitis: a randomized, double-blind, placebo-controlled trial. Pulm Pharmacol Ther 2014; 27: 102-108
  • 5 Fashner J, Ericson K, Werner S. Treatment of the common cold in children and adults. Am Fam Physician. 2012; 86: 153-159
  • 6 Kardos P, Berck H, Fuchs KH. et al. Guidelines of the german respiratory society for diagnosis and treatment of adults suffering from acute or chronic cough. Pneumologie 2010; 64: 336-373
  • 7 Francis NA, Gillespie D, Nuttall J. et al. Antibiotics for acute cough: An international observational study of patient adherence in primary care. Br J Gen Pract 2012; e429-e437
  • 8 Blessing B. Pathways of Homoeopathic Medicine. Heidelberg: Springer Medizin Verlag; 2011
  • 9 Petrucci R. Kinder - Ausgewählte Repertoriumsrubriken und Arzneimittelbilder. 2008; ISBN 978-3-929271-31-7. Hahnemann Institut
  • 10 Wiesenauer M, Elies M. Pädiatrische Praxis der Homöopathie. 1998; , ISBN 978-3-7773-1174-6, Hippokrates-Verlag
  • 11 Cucherat M, Haugh MC, Gooch M. et al. Evidence of clinical efficacy of homeopathy. A meta-analysis of clinical trials. HMRAG. Homeopathic Medicines Research Advisory Group. Eur J Clin Pharmacol. 2000; 56: 27-33
  • 12 Kleijnen J, Knipschild P, ter Riet G. Clinical trials of homoeopathy. BMJ 1991; 302: 9 Feb
  • 13 Linde K, Clausius N, Ramirez G. et al. Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controlled trials. Lancet 1997; 350: 834-843
  • 14 Lüdtke R, Rutten AL. The conclusions on the effectiveness of homeopathy highly depend on the set of analyzed trials. J Clin Epidemiol 2008; 61: 1197-1204
  • 15 Shang A, Huwiler-Müntener K, Nartey L. et al. Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet 2015; 366: 726-732
  • 16 Committee for Medicinal Products for Human Use/Paediatric Committee. Guideline on pharmaceutical development of medicines for paediatric use. EMA/CHMP/QWP/805880/2012 Rev. 2. 1 August
  • 17 Newcombe PA, Sheffield JK, Chang AB. Parent cough-specific quality of life: development and validation of a short form. J Allergy Clin Immunol. 2013; 131: 1069-1074
  • 18 Grünwald J, Graubaum H-J, Busch R. Efficacy and Tolerability of a fixed Combination of Thyme and Primerose Root in Patients with acute bronchitis. Drug Res 2005; 55: 669-676
  • 19 MedDRA Introductory Guide Version 14.0. March 2011. http://www.who.int/medical_devices/innovation/MedDRAintroguide_version14_0_March2011.pdf
  • 20 Michalsen A, Uehleke B, Stange R. Safety and compliance of a complex homeopathic drug (Contramutan N Saft) in the treatment of acute respiratory tract infections: A large observational (non-interventional) study in children and adults focussing on homeopathy specific adverse reactions versus adverse drug reactions. Regul Toxicol Pharmacol 2015; 72: 179-184
  • 21 Directive 2001/20/EC of the European parliament and the council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use